This inventor holds 1 USPTO granted patent. Top assignee: Sankyo Company, Limited. Active years: 1999.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1999
Title: Sebastian Lazareno: Innovator in Therapeutic Compounds
Introduction
Sebastian Lazareno is a notable inventor based in Ware, GB. He has made significant contributions to the field of medicinal chemistry, particularly in the development of heterocyclic compounds. His work focuses on creating compounds that have therapeutic applications, especially in treating neurological disorders.
Latest Patents
Lazareno holds a patent for "Heterocyclic compounds, their preparation and their therapeutic use." This patent describes a compound of formula (I) wherein various substituents can be hydrogen, halogen, nitro, cyano, hydroxyl, thiol, amino, alkyl, haloalkyl, alkylthio, a protected or unprotected carboxyl, a protected or unprotected sulfonamide, or tetrazol. The compounds are particularly effective for treating dementia, Alzheimer's disease, and delirium, and they also serve as sedatives. He has 1 patent to his name.
Career Highlights
Lazareno is associated with Sankyo Company, Limited, where he continues to innovate in the field of pharmaceuticals. His research has the potential to impact the treatment of cognitive disorders significantly.
Collaborations
He has collaborated with notable colleagues such as Masahiko Sugimoto and Nigel Birdsall, contributing to a dynamic research environment that fosters innovation.
Conclusion
Sebastian Lazareno's work in developing therapeutic compounds showcases his commitment to advancing medical science. His contributions are vital in the ongoing fight against neurological disorders, and his innovative spirit continues to inspire others in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile